坦桑尼亚动脉瘤性蛛网膜下腔出血的当前治疗管理、流行趋势与结果:Muhimbili骨科与神经外科研究所单中心经验
本研究回顾性分析了2019年2月至2021年6月在坦桑尼亚MOI确诊的22例aSAH患者(24个动脉瘤),女/男比1.4,中位年龄54岁。14例(63.6%)接受夹闭术,其中仅4例(28.6%)在72小时内手术;非手术组死亡率为62.5%,夹闭组78.6%预后良好且无死亡。结论认为这是坦桑尼亚首个aSAH管理研究,显示与国际指南存在差异,术前高死亡率源于治疗延迟。
要点
- 22例aSAH患者中14例(63.6%)接受夹闭术,仅4例(28.6%)在72小时内手术。
- 非手术组死亡率为62.5%,夹闭组78.6%预后良好且无死亡。
- 坦桑尼亚无血管内治疗,13例(59.1%)自费支付医疗费用。
核心结论
- 这是首个突出坦桑尼亚aSAH管理及其优势与不足的研究。
- 数据显示与国际治疗指南存在显著差异,结果如因治疗延迟/推迟导致的高术前死亡率。
- 尽管地区条件困难,长期目标是显著改善坦桑尼亚aSAH的整体管理。
研究设计与样本
- 回顾性研究,纳入2019年2月至2021年6月经CT/MR血管造影确诊的aSAH患者。
- 共分析22例患者(24个动脉瘤),女/男比为1.4,中位年龄54岁(IQR 47.2-63岁)。
- 分析参数包括人口学、临床/影像学特征、损伤特征及改良Rankin量表(mRS)评分。
主要发现
- 13例(59.1%)自费支付;患者中位旅行距离537 km(IQR 34.7-635 km);入院至治疗中位时间12天(IQR 3.2-39天)。
- 最常见症状为头痛(n=20;90.9%)和高血压(n=10;45.4%)。
- 9例(40.9%)Fisher分级1级,12例(54.5%)世界神经外科医师联盟分级I级;最常见动脉瘤为大脑中动脉(7/29.2%)。
- 14例(63.6%)接受夹闭术,其中仅4例(28.6%)在72小时内手术;非手术组死亡率为62.5%。
- 夹闭患者中78.6%预后良好,无死亡;坦桑尼亚无血管内治疗。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In Africa, no cerebral aneurysm treatment guidelines exist. Epidemiology, management, and outcomes after aneurysmal subarachnoid hemorrhage (aSAH) remain poorly understood, with many underdiagnosed cases. Muhimbili Orthopaedic and Neurosurgery Institute (MOI) is the only neurosurgical referral center in Tanzania. The aim of this study is to describe the current aSAH management with regional outcomes and limitations. METHODS: Patients with aSAH confirmed by computed tomography/magnetic resonance angiography between February 2019 and June 2021 were retrospectively studied. The analyzed parameters included demographics, clinical/radiologic characteristics, injury characteristics, and the modified Rankin Scale (mRS) score. RESULTS: In total, 22 patients, with a female/male ratio of 1.4 and a median age of 54 years (interquartile range [IQR], 47.2-63 years) harboring 24 aneurysms were analyzed. Thirteen patients (59.1%) paid out of pocket. The median distance traveled by patients was 537 km (IQR, 34.7-635 km). The median time between admission and treatment was 12 days (IQR, 3.2-39 days). The most common symptoms were headache (n = 20; 90.9%) and high blood pressure (n = 10; 45.4%). Nine patients (40.9%) had Fisher grade 1 and 12 (54.5%) World Federation of Neurosurgical Societies grade I. The most common aneurysms were of the middle cerebral artery (7/29.2%). Fourteen patients (63.6%) underwent clipping; of those, only 4 (28.6%) were operated on within 72 hours. Mortality was 62.5% in the nonsurgical group. Among clipped patients, 78.6% showed favorable outcomes, with no mortality. Endovascular treatment is not available in Tanzania. CONCLUSIONS: To our best knowledge, this is the first study highlighting aSAH management in Tanzania, with its assets and shortcomings. Our data show pertinent differences among international treatment guidelines, with the resultant outcomes, such as high preoperative mortality resulting from delayed/postponed treatment. Regional difficult circumstances notwithstanding, our long-term goal is to significantly improve the overall management of aSAH in Tanzania.
引用
- Waterkeyn F, Lohkamp LN, Ikwuegbuenyi CA, et al. Current Treatment Management of Aneurysmal Subarachnoid Hemorrhage with Prevailing Trends and Results in Tanzania: A Single-Center Experience at Muhimbili Orthopedic and Neurosurgery Institute. World Neurosurg. 2022. PMID: 36336272. doi:10.1016/j.wneu.2022.11.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。